1. Gender-specific contributing risk factors and outcome of female cryptococcal meningoencephalitis patients
- Author
-
Mingyue Li, Ningfen Chen, Jialing Yang, Qiong Chen, Dongmei Wang, Junying Lao, Yang Man, Hui Zheng, Suyue Pan, and Xiaomei Zhang
- Subjects
Adult ,Male ,0301 basic medicine ,medicine.medical_specialty ,Multivariate analysis ,030106 microbiology ,03 medical and health sciences ,Sex Factors ,0302 clinical medicine ,Medical microbiology ,Contributing risk factor ,Adrenal Cortex Hormones ,Meningoencephalitis ,Risk Factors ,Statistical significance ,Internal medicine ,Humans ,Lupus Erythematosus, Systemic ,Medicine ,030212 general & internal medicine ,Risk factor ,Retrospective Studies ,Univariate analysis ,Gender-specific ,business.industry ,Proportional hazards model ,Survival length ,Retrospective cohort study ,medicine.disease ,Treatment Outcome ,Infectious Diseases ,Retrospective research ,Multivariate Analysis ,Immunology ,Female ,Cryptococcal meningoencephalitis ,business ,Immunosuppressive Agents ,Research Article - Abstract
Background Although male predominance was documented in previous studies on cryptococcal meningoencephalitis (CM), there has been no statistical study about female CM patients despite recently noticeable increase in female prevalence. In the current study, we aimed to investigate the independent gender-specific contributing risk factors for onset of CM and factors related to survival time in female patients by chosen statistical tools. Methods There have been 108 patients diagnosed with CM from July 1, 1998 to June 30, 2013 in Nanfang Hospital that were included in our study. This 15-year retrospective study compared demographic and clinical features of 31 female patients with 77 males. Multivariate analysis was performed for detection of the contributors to the onset of CM in female patients. The independent variables for multivariate analysis were selected according to statistical significance in univariate analysis. Furthermore, Cox regression model was used to evaluate the factors related to survival length. Results Use of corticosteroids or other immunosuppressants (32.3 % versus 11.7 %; p = 0.011) and history of systemic lupus erythematosus (SLE) and other autoimmune diseases (29 % versus 3.9 %; p
- Published
- 2015
- Full Text
- View/download PDF